SEARCH

SEARCH BY CITATION

References

  • 1
    Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56: 813824.
  • 2
    Almén T. The etiology of contrast medium reactions. Invest Radiol 1994;29: S37S45.
  • 3
    Munechika H, Hiramatsu Y, Kudo S, Sugimura K, Hamada C, Yamaguchi K et al. A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography. Eur Radiol 2003;13: 185194.
  • 4
    Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990;175: 621628.
  • 5
    Wolf GL, Arenson RL, Cross AP. A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: Comparison of adverse effects. Am J Roentgenol 1989;152: 939944.
  • 6
    Palmer FJ. The RACR survey of intravenous contrast media reactions. Final report. Australas Radiol 1988;32: 426428.
  • 7
    Caro JJ, Trindade E, McGregor M. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis. Am J Roentgenol 1991;156: 825832.
  • 8
    Christiansen C. X-ray contrast media – an overview. Allergologie 2004;27: 165 (abstract no. 57).
  • 9
    Webb JA, Stacul F, Thomsen HS, Morcos SK. Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 2003;13: 181184.
  • 10
    Schild H. Delayed allergy-like reactions in patients: monomeric and dimeric contrast media compared with plain CT. Eur Radiol 1996;6 (insert to issue 5): 910.
  • 11
    Yasuda R, Munechika H. Delayed adverse reactions to nonionic monomeric contrast-enhanced media. Invest Radiol 1998;33: 15.
  • 12
    Hosoya T, Yamaguchi K, Akutsu T, Mitsuhashi Y, Kondo S, Sugai Y et al. Delayed adverse reactions to iodinated contrast media and their risk factors. Radiat Med 2000;18: 3945.
  • 13
    Rydberg J, Charles J, Aspelin P. Frequency of late allergy-like adverse reactions following injection of intravascular non-ionic contrast media. A retrospective study comparing a non-ionic monomeric contrast medium with a non-ionic dimeric contrast medium. Acta Radiol 1998;39: 219222.
  • 14
    Christiansen C, Pichler WJ, Skotland T. Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations. Eur Radiol 2000;10: 19651975.
  • 15
    Sutton AG, Finn P, Grech ED, Hall JA, Stewart MJ, Davies A et al. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am Heart J 2001;141: 677683.
  • 16
    Savader SJ, Brodkin J, Osterman FA. Delayed life-threatening reaction to non-ionic contrast media. J Invest Radiol 1995;10: 115116.
  • 17
    Miyamoto Y, Tatei T, Ichijima S, Nakayama M, Oono K, Yamashita M. Delayed eruption caused by non-ionic contrast material injection. J Jpn Radiol Assoc 1990;50: 295297.
  • 18
    Brockow K, Kiehn M, Kleinheinz A, Vieluf D, Ring J. Positive skin tests in late reactions to radiographic contrast media. Allerg Immunol (Paris) 1999;31: 4951.
  • 19
    Stovsky MD, Seftel AD, Resnick MI. Delayed hypersensitivity reaction after infusion of nonionic intravenous contrast material for an excretory urogram: a case report and review of the literature. J Urol 1995;153: 16411643.
  • 20
    Choyke PL, Miller DL, Lotze MT, Whiteis JM, Ebbitt B, Rosenberg SA. Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology 1992;183: 111114.
  • 21
    Yoshikawa H. Late adverse reactions to nonionic contrast media. Radiology 1992;183: 737740.
  • 22
    Ansell G, Tweedie MC, West CR, Evans P, Couch L. The current status of reactions to intravenous contrast media. Invest Radiol 1980;15: S32S39.
  • 23
    Yocum MW, Heller AM, Abels RI. Efficacy of intravenous pretesting and antihistamine prophylaxis in radiocontrast media-sensitive patients. J Allergy Clin Immunol 1978;62: 309313.
  • 24
    Wolf GL, Mishkin MM, Roux SG, Halpern EF, Gottlieb J, Zimmerman J et al. Comparison of the rates of adverse drug reactions. Ionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26: 404410.
  • 25
    Bettmann MA, Heeren T, Greenfield A, Goudey C. Adverse events with radiographic contrast agents: results of the SCVIR contrast agent registry. Radiology 1997;203: 611620.
  • 26
    Lang DM, Alpern MB, Visintainer PF, Smith ST. Increased risk for anaphylactoid reaction from contrast media in patients on β-adrenergic blockers or with asthma. Ann Intern Med 1991;115: 270276.
  • 27
    Lang DM, Alpern MB, Visintainer PF, Smith ST. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both β-blocker exposure and cardiovascular disorders. Arch Intern Med 1993;153: 20332040.
  • 28
    Aoki Y, Takemura T. Allergies correlated to adverse reactions induced by non-ionic monomeric and ionic dimeric contrast media for contrast enhanced CT examination. Jpn J Radiol Technol 2002;58: 12451251.
  • 29
    Pichler WJ, Yawalkar N, Britschgi M, Depta J, Strasser I, Schmid S et al. Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol 2002;3: 229238.
  • 30
    Pichler WJ, Yawalkar N. Allergic reactions to drugs: involvement of T cells. Thorax 2000;55(Suppl. 2): 561565.
  • 31
    Laroche D, Aimone-Gastin I, Dubois F, Huet H, Gérard P, Vergnaud M-C et al. Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 1998;209: 183190.
  • 32
    Mita H, Tadokoro K, Akiyama K. Detection of IgE antibody to a radiocontrast medium. Allergy 1998;53: 11331140.
  • 33
    Sweeney MJ, Klotz SD. Frequency of IgE mediated radio contrast dye reactions. J Allergy Clin Immunol 1983;71: 147.
  • 34
    Dewachter P, Mouton-Faivre C, Felden F. Allergy and contrast media. Allergy 2001;56: 250251.
  • 35
    Wakkers-Garritsen BG, Houwerziji J, Nater JP, Wakkers PJ. IgE-mediated adverse reactivity to a radiographic contrast medium. Ann Allergy 1976;36: 122126.
  • 36
    Kanny G, Maria Y, Mentre B, Moneret-Vautrin DA. Case report: recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgE-mediated reaction. Allerg Immunol (Paris) 1993;25: 425430.
  • 37
    Patriarca G, Venuti A, Schiavino D, Romano A. Specific desensitizing treatment in allergy to iodine-containing contrast media: observation in one patient. Ann Allergy 1978;40: 200202.
  • 38
    Alvarez-Fernández JA, Valero AM, Pulido Z, de la Hoz B, Cuevas M, Sánchez-Cano M. Hypersensitivity reaction to ioversol. Allergy 2000;55: 581582.
  • 39
    Laroche D, Namour F, Lefrancois C, Aimone-Gastin I, Romano A, Sainte-Laudy J et al. Anaphylactoid and anaphylactic reactions to iodinated contrast material. Allergy 1999;54: 1316.
  • 40
    Moneret-Vautrin DA, Kanny G, Morisset M, Beaudouin E, Renaudin JM. Anaphylactoid reactions and late skin reactions to iodinated contrast media: present state of the question – development of ideas. Rev Med Interne 2001;22: 969977.
  • 41
    Laroche D, Dewachter P, Mouton-Faivre C, Clément O. Immediate reactions to iodinated contrast media: the CIRTACI study. Allergologie 2004;27: 165 (abstract no. 56).
  • 42
    Yamauchi R, Morita A, Tsuji T. Fixed drug eruption caused by iopamidol, a contrast medium. J Dermatol 1997;24: 243245.
  • 43
    Watanabe H, Sueki H, Nakada T, Akiyama M, Iijima M. Multiple fixed drug eruption caused by iomeprol (Iomeron®), a nonionic contrast medium. Dermatology 1999;198: 291294.
  • 44
    Brockow K, Becker EW, Worret W-I, Ring J. Late skin test reactions to radiocontrast medium. J Allergy Clin Immunol 1999;104: 11071108.
  • 45
    Kanzaki T, Sakagami H. Late phase allergic reaction to a CT contrast medium (iotrolan). J Dermatol 1991;18: 528531.
  • 46
    Schick E, Weber L, Gall H. Delayed hypersensitivity reaction to the non-ionic contrast medium iopromid. Contact Dermatitis 1996;35: 312.
  • 47
    Gall H, Pillekamp H, Peter R-U. Late-type allergy to the X-ray contrast medium Solutrast® (iopamidol). Contact Dermatitis 1999;40: 248250.
  • 48
    Otto K, Kaempgen E, Dummer W, Broecker E-B, Becker JC. Late-type allergy to Ultravist® (iopromid). Allergy 2003;58: 261262.
  • 49
    Kanny G, Marie B, Hoen B, Trechot P, Moneret-Vautrin DA. Delayed adverse reaction to sodium ioxaglic acid-meglumine. Eur J Dermatol 2001;11: 134137.
  • 50
    Rosado A, Canto G, Veleiro B, Rodríguez J. Toxic epidermal necrolysis after repeated injections of iohexol. Am J Roentgenol 2001;176: 262263.
  • 51
    Sedano E, Vega JM, Rebollo S, Callejo A, Asensio T, Almendros R. Delayed exanthema to nonionic contrast medium. Allergy 2001;56: 10151016.
  • 52
    Erdmann S, Roos T, Merk HF. Delayed hypersensitivity reaction to the nonionic contrast medium ioversol. Zeitschrift für Haut- und Geschlechtskrankheiten 2000;75: 169171.
  • 53
    Romano A, Artesani MC, Andriolo M, Viola M, Pettinato R, Vecchioli-Scaldazza A. Effective prophylactic protocol in delayed hypersensitivity to contrast media: report of a case involving lymphocyte transformation studies with different compounds. Radiology 2002;225: 466470.
  • 54
    Akiyama M, Nakada T, Sueki H, Fujisawa R, Iijima M. Drug eruption caused by nonionic iodinated X-ray contrast media. Acad Radiol 1998;5: S159S161.
  • 55
    Courvoisier S, Bircher AJ. Delayed-type hypersensitivity to a nonionic, radiopaque contrast medium. Allergy 1998;53: 12211224.
  • 56
    Christiansen C, Dreborg S, Pichler WJ, Ekeli H. Macular exanthema appearing 5 days after X-ray contrast medium administration. Eur Radiol 2002;12: S94S97.
  • 57
    Vernassiere C, Trechot P, Commun N, Schmutz J-L, Barbaud A. Low negative predictive value of skin tests in investigating delayed reactions to radio-contrast media. Contact Dermatitis 2004;50: 359–366.
  • 58
    Sánchez-Pérez J, F-Villaltta MG, Ruíz SA, Garcia Diez A. Delayed hypersensitivity reaction to the non-ionic X-ray contrast medium Visipaque® (iodixanol). Contact Dermatitis 2003;48: 167.
  • 59
    Ángeles Gonzalo-Garijo M, de Argila D, Pimentel JJ, Alejo M, García-Menaya JM. Skin reaction to contrast medium. Allergy 1997;52: 875876.
  • 60
    Savill JS, Barrie R, Ghosh S, Muhlemann M, Dawson P, Pusey CD. Fatal Stevens–Johnson syndrome following urography with iopamidol in systemic lupus erythematosus. Postgrad Med J 1988;64: 392394.
  • 61
    Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity: questionnaire. Allergy 1999;54: 9991003.
  • 62
    Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977;1: 466469.
  • 63
    Brockow K, Vieluf D, Püschel K, Grosch J, Ring J. Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium. J Allergy Clin Immunol 1999;104: 237238.
  • 64
    Laroche D, Vergnaud M-C, Sillard B, Soufarapis H, Bricard H. Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase. Anesthesiology 1991;75: 945949.
  • 65
    Assem ES, Bray K, Dawson P. The release of histamine from human basophils by radiological contrast agents. Br J Radiol 1983;56: 647652.
  • 66
    Ring J, Arroyave CM, Frizler MJ, Tan EM. In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement-dependent and independent release reaction and changes in ultrastructure of human blood cells. Clin Exp Immunol 1978;32: 105118.
  • 67
    Siegle RL, Lieberman P, Jennings BR, Rice MC. Iodinated contrast material: studies relating to complement activation, atopy, cellular association, and antigenicity. Invest Radiol 1980;15: S13S17.
  • 68
    Ring J, Simon RA, Arroyave CM. Increased in vitro histamine release by radiographic contrast media in patients with history of incompatibility. Clin Exp Immunol 1978;34: 302309.
  • 69
    Fischer HW, Doust VL. An evaluation of pretesting in the problem of serious and fatal reactions to excretory urography. Radiology 1972;103: 497501.
  • 70
    Witten DM, Hirsch FD, Hartman GW. Acute reactions to urographic contrast medium: incidence, clinical characteristics and relationship to history of hypersensitivity states. Am J Roentgenol 1973;119: 832840.
  • 71
    Yamaguchi K, Katayama H, Takashima T, Kozuka T, Seez P, Matsuura K. Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1991;178: 363367.
  • 72
    Goodfellow T, Holdstock GE, Brunton FJ, Bamforth J. Fatal acute vasculitis after high-dose urography with iohexol. Br J Radiol 1986;59: 620621.
  • 73
    Barbaud A, Goncalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001;45: 321328.
  • 74
    Morcos SK, Thomsen HS, Webb JA. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol 2001;11: 17201728.
  • 75
    Cohan RH, Ellis JH, Dunnick NR. Use of low-osmolar agents and premedication to reduce the frequency of adverse reactions to radiographic contrast media: a survey of the Society of Uroradiology. Radiology 1995;194: 357364.
  • 76
    Roberts M, Fisher M. Anaphylactoid reaction to iopamiro (after pretreatment). Australas Radiol 1992;36: 144146.
  • 77
    Madowitz JS, Schweiger MJ. Severe anaphylactoid reaction to radiographic contrast media. Recurrence despite premedication with diphenhydramine and prednisone. JAMA 1979;241: 28132815.
  • 78
    Ketkar M, Shrier D. An allergic reaction to intraarterial nonionic contrast material. Am J Neuroradiol 2003;24: 292.
  • 79
    Freed KS, Leder RA, Alexander C, DeLong DM, Kliewer MA. Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication. Am J Roentgenol 2001;176: 13891392.
  • 80
    Borofsky HB, Barnard CM, Lang EV. Fixed bullous drug eruption due to iohexol. Adv X-Ray Contrast 1993;1: 5860.